APA (7th ed.) Citation

P, B., KE, B., M, D., BW, C., A, O., RW, G., & DJ, B. (2020). Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of laminin-α2 related congenital muscular dystrophy. Human molecular genetics, 29(13), 2162. https://doi.org/10.1093/hmg/ddaa104

Chicago Style (17th ed.) Citation

P, Barraza-Flores, Bukovec KE, Dagda M, Conner BW, Oliveira-Santos A, Grange RW, and Burkin DJ. "Laminin-111 Protein Therapy After Disease Onset Slows Muscle Disease in a Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy." Human Molecular Genetics 29, no. 13 (2020): 2162. https://doi.org/10.1093/hmg/ddaa104.

MLA (9th ed.) Citation

P, Barraza-Flores, et al. "Laminin-111 Protein Therapy After Disease Onset Slows Muscle Disease in a Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy." Human Molecular Genetics, vol. 29, no. 13, 2020, p. 2162, https://doi.org/10.1093/hmg/ddaa104.